Liquid Chromatography–Tandem Mass Spectrometry in Newborn Screening Laboratories
Michael H. Gelb(University of Washington), Dietrich Matern(Mayo Clinic), Coleman Turgeon(Mayo Clinic), Frédéric M. Vaz(Netherlands Metabolomics Centre), Khaja Basheeruddin(Rush University Medical Center), Nicolas Szabo‐Fresnais(Utah Department of Health), Xinying Hong(University of Washington), Adrienne Manning(Connecticut Department of Public Health), Joseph J. Orsini, Andreas Rohrwasser(Utah Department of Health), Enzo Ranieri(Women's and Children's Hospital), Hsuan-Chieh Liao(University of Washington), Alberto Burlina(University of Padua), Amy Hietala(Minnesota Department of Health), George J. Dizikes, Hsiao-Jan Chen, Roberto Giugliani(Universidade Federal do Rio Grande do Sul), Francyne Kubaski(Universidade Federal do Rio Grande do Sul), M. Christine Dorley(Tennessee Department of Health), Liyun Wang(Binzhou Medical University), Yin Peng(Shenzhen University Health Science Center), Hamid Khaledi, Monica Martin(Pediatrics and Genetics), Yin‐Hsiu Chien(National Taiwan University Hospital), Shu‐Min Kao, Tracy Klug(Missouri Department of Health and Senior Services)
Cited by 46
Related Papers
Modeling the mitochondrial cardiomyopathy of Barth syndrome with induced pluripotent stem cell and heart-on-chip technologies
|Nature Medicine|2014|843
Proposed guidelines for the diagnosis and management of methylmalonic and propionic acidemia
|Orphanet Journal of Rare Diseases|2014|713
The Effect of Weight Loss on the Sensitivity of Blood Pressure to Sodium in Obese Adolescents
|New England Journal of Medicine|1989|625
Characterization of human disease phenotypes associated with mutations in <i>TREX1</i>, <i>RNASEH2A</i>, <i>RNASEH2B</i>, <i>RNASEH2C</i>, <i>SAMHD1</i>, <i>ADAR</i>, and <i>IFIH1</i>
|American Journal of Medical Genetics Part A|2015|617
Treatment of Fabry’s Disease with the Pharmacologic Chaperone Migalastat
|New England Journal of Medicine|2016|555